Nektar Therapeutics (NKTR)
57.74
-1.04
(-1.77%)
USD |
NASDAQ |
Dec 10, 16:00
57.66
-0.08
(-0.14%)
After-Hours: 20:00
Nektar Therapeutics EPS Diluted (Quarterly): -1.875 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
| Zevra Therapeutics, Inc. | -0.0097 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.52M |
| Revenue (Quarterly) | 11.79M |
| Total Expenses (Quarterly) | 47.31M |
| Enterprise Value | 895.80M |
| Gross Profit Margin (Quarterly) | 98.34% |
| Profit Margin (Quarterly) | -301.3% |
| Earnings Yield | -7.90% |
| Normalized Earnings Yield | -7.731 |